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Peptide–membrane interactions have been implicated in both the toxicity and aggregation of β-amyloid (Aβ) peptides. Recent studies have
provided evidence for the involvement of liquid-ordered membrane domains known as lipid rafts in the formation and aggregation of Aβ. As a
model, we have examined the interaction of Aβ(1−42) with phase separated DOPC/DPPC lipid bilayers using a combination of atomic force
microscopy (AFM) and total internal reflection fluorescence microscopy (TIRF). AFM images show that addition of Aβ to preformed supported
bilayers leads to accumulation of small peptide aggregates exclusively on the gel phase DPPC domains. Initial aggregates are observed
approximately 90 min after peptide addition and increase in diameter to 45–150 nm within 24 h. TIRF studies with a mixture of Aβ and Aβ–Fl
demonstrate that accumulation of the peptide on the gel phase domains occurs as early as 15 min after Aβ addition and is maintained for over 24 h.
By contrast, Aβ is randomly distributed throughout both fluid and gel phases when the peptide is reconstituted into DOPC/DPPC vesicles prior to
formation of a supported bilayer. The preferential accumulation of Aβ on DPPC domains suggests that rigid domains may act as platforms to
concentrate peptide and enhance its aggregation and may be relevant to the postulated involvement of lipid rafts in modulating Aβ activity in vivo.
© 2006 Elsevier B.V. All rights reserved.Keywords: β-amyloid peptide; Atomic force microscopy; Bilayer; Fluourescence1. Introduction
Alzheimer's disease (AD) is a chronic neurological disease,
leading to progressive mental degeneration and irreversible
dementia. Pathologically, AD is characterized by the presence
of neurofibrillary tangles and extracellular senile plaques in
affected areas of the brain [1]. The main constituent of these
plaques is β-amyloid (Aβ), a 39 to 43 amino acid peptide,
produced intracellularly from the enzymatic cleavage of a
transmembrane protein known as amyloid precursor protein
(APP) [2]. Genetic data suggest that Aβ is involved in theAbbreviations: AD, Alzheimer's disease; Aβ, Amyloid β; APP, amyloid
precursor protein; AFM, atomic force microscopy; DOPC, 1,2-dioleoyl-sn-
glycero-3-phosphocholine; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocho-
line; TIRF, total internal reflection fluorescence; TR-DHPE, Texas Red® 1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt
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doi:10.1016/j.bbamem.2006.09.005pathogenesis of AD [3], and several in vitro studies show a clear
correlation between the aggregation and fibrillation of Aβ, and
its neurotoxicity [4,5]. Traditionally, insoluble plaques and
fibrils of Aβ were believed to be responsible for the
neurological degeneration observed in AD. However, more
recent studies show that small diffusible nonfibrillar oligomers
of Aβ [6–9] as well as intermediate species formed during Aβ
fibrillation (protofibrils) [10] are also toxic to cultured neurons.
It has been suggested that plaques may act as a reservoir of
species in equilibrium with small neurotoxic oligomers [11].
Recently, it was reported that soluble oligomers of Aβ are
responsible for memory deficits in middle aged rats occurring
prior to tangles or plaque formation; these oligomers could also
induce memory impairment when injected into young rats [12].
Despite the growing body of evidence that links Aβ to AD, the
exact mechanism through which soluble monomers of Aβ
aggregate in vivo, interact with cellular membranes and elicit a
neurotoxic effect is still not clear [1].
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action of β-amyloid. Among these, non-specific interactions
with lipid membranes have been implicated in both Aβ
aggregation and toxicity [13]. For example, it was shown that
membrane components such as cholesterol and gangliosides
enhance the binding of Aβ to lipid bilayers, and act as seeds that
promote the self-aggregation of the peptide [14–16]. It was also
reported that the interaction of Aβwith negatively charged lipids
or with gangliosides induces a change in the peptide secondary
structure and promotes the formation of the β-sheet structure
that is required for Aβ aggregation [17–20]. Other studies have
demonstrated that the addition of Aβ to lipid vesicles compro-
mises the membrane integrity, causing leakage of dye molecules
encapsulated in the vesicle interior [19,21,22]. Aβ was also
reported to form ion-channels in planar lipid bilayers and lipid
vesicles, and to induce neurotoxicity by altering the ionic
homoeostasis [23–27].
Most studies of the interaction of Aβ with model membranes
have examinedAβ(1–40) which accounts for the largest fraction
of secreted Aβ peptides. However, the more hydrophobic
Aβ(1–42) is the predominant component in senile plaques [28]
and displays enhanced neurotoxicity. Aβ(1–42) is an amphi-
philic peptide, consisting of a polar N-terminal domain (residues
1–28) and a hydrophobic C-terminal (residues 29–42), and is
more prone to aggregation than Aβ(1–40) [29,30]. Recent
studies indicate that the two peptides oligomerize though distinct
pathways [31] and there is conflicting evidence concerning the
propensity of Aβ(1–42) to insert into and disrupt bilayer
membranes. For instance, McLaurin et al. reported that Aβ(1–
40) is more effective in inducing dye leakage from vesicles than
Aβ(1–42) [19,21]. By contrast, other studies have shown that
Aβ(1–42) forms channels and disrupts membranes [22,24].
Both Aβ and APP have been identified in lipid rafts isolated
as detergent resistant membrane fractions from both cultured
cells and brain [32–34]. Lipid rafts are microdomains that are
rich in saturated lipids and cholesterol and that play an important
role in aggregation of proteins for signal transduction and
membrane trafficking [35,36]. Recent studies have shown that
the cleavage of APP to produce Aβ peptides is regulated by the
partitioning of APP and the β-secretase cleavage enzyme into
lipid rafts [37] and that accumulation of dimeric Aβ and APP in
lipid rafts may be linked to memory impairment [38]. The
potential role of membrane domains in formation and aggrega-
tion of Aβ peptides has prompted us to examine the interaction
of Aβ(1–42) with ordered lipid domains as a model for micro-
domains in cellular membranes. We have used a combination of
atomic forcemicroscopy (AFM) and fluorescencemicroscopy to
probe the interaction of Aβ(1−42) with phase separated lipid
bilayers prepared from DOPC/DPPC mixtures. Although
several previous studies have used AFM to study the interaction
of amyloid peptides with supported bilayers [20,24,39,40], this
is the first example in which phase-separated membranes are
examined. We have also used peptide concentrations that are
below those required for aggregation in solution. The results
demonstrate that addition of Aβ to preformed lipid bilayers leads
to selective accumulation of the peptide on ordered gel phase
domains, rather than the fluid phase, and eventually to formationof small spherical aggregates. By contrast, the peptide is
distributed in both gel and fluid phases when it is incorporated
in the lipid bilayer during vesicle formation. These results
highlight the importance of membrane composition in control-
ling the behavior of Aβ, even for simple phosphatidylcholine
mixtures in the absence of either cholesterol or charged lipids,
and may have implications for the role of lipid rafts in
modulating Aβ activity in vivo.
2. Materials and methods
2.1. Materials
1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC) and 1,2-Dipalmitoyl-
sn-Glycero-3-Phosphocholine (DPPC) were obtained from Avanti Polar Lipids
(Alabaster, AL). Texas Red® 1,2-dihexadecanoyl-sn-glycero-3-phosphoethano-
lamine, triethylammonium salt (TR-DHPE) was obtained from Invitrogen
Canada Inc. HPLC-grade chloroform (Fisher Scientific) and Milli-Q water,
deionized to a resistivity of 18.5 MΩcm, were used in all of the experiments. β-
Amyloid (1–42) peptide was purchased from Biopeptide Co., Inc. (San Diego,
CA), and Fluorescein-β-Amyloid (1–42) (Fl–Aβ) from AnaSpec, Inc. (San
Jose, CA). Both manufacturer's guarantee peptide purity >95% as determined
by HPLC. The peptide was treated with 1 mM NaOH according to a literature
procedure [41], lyophilized and stored at −80 °C. Before its addition to a lipid
bilayer, the peptide was dissolved in 50 mM HEPES buffer (pH=7.8). Gel
electrophoresis shows that the sodium hydroxide pretreatment gives predomi-
nantly monomeric Aβ, in agreement with literature results [41]. CD spectro-
scopy of freshly prepared solutions of ∼60 μM Aβ shows minimal signal at
218 nm due to β-sheet; the signal due to β-sheet increases with time with a
maximal yield obtained after 2 days incubation in solution at room temperature.
2.2. Vesicle preparation
Lipid stock solutions were prepared in chloroform and aliquots were mixed
in a glass vial to give a DOPC:DPPC molar ratio of 1:1. In the case of Aβ-
reconstituted vesicles, the peptide was mixed with the lipids to give a peptide to
lipid molar ratio of 1:130. Chloroform was evaporated under a gentle stream of
nitrogen gas, and the resulting lipid film was dried under vacuum overnight to
remove trace amounts of solvent. The film was hydrated with Milli-Q water
(final lipid concentration of 1 mg/ml) and vortexed for 2–3 min. The obtained
turbid solution of multilamellar vesicles was then sonicated in a bath sonicator
(Branson Instruments) at 38–42 °C to clarity (20–30 min).
2.3. Bilayer formation and AFM imaging
Supported lipid bilayers were prepared using the method of vesicle fusion.
Briefly, to a piece of freshly cleaved mica clamped to the AFM liquid cell
(Molecular Imaging), 300 μl of CaCl2 (50 mM) and 150 μl of vesicle solution
were added. The solution was incubated at room temperature for 30 min, which
proved to be a sufficient time for the vesicles to fuse and rupture to form a
uniform bilayer on mica. Prior to imaging, the bilayer was rinsed extensively
with Milli-Q water to remove excess lipids and CaCl2.
AFMmeasurements for all bilayers were carried out on a Mac mode PicoSPM
atomic force microscope (Molecular Imaging Inc.) in aqueous solution. Magnetic
coated silicon tips (Mac Lever type II) with a force constant=2.8 N/m and a
resonance frequency in water between 20 and 25 kHz were used for wet imaging.
The scan rate was kept at 1 Hz or less. After imaging the lipid bilayer, 10 μg of
Aβ(1–42) were added to the AFM cell (final peptide concentration ≈ 3 μM) and
the sample was incubated at room temperature. The bilayer was subsequently
imaged at various time points. Several bilayers were prepared independently and
incubated with Aβ. For each sample, several areas were scanned.
2.4. Peptide aggregation in solution and AFM imaging
Aβ(1–42) or a mixture of unlabeled and Fl–Aβ (10% w/w) were incubated
in HEPES buffer (50 mM; pH=7.8) at 37 °C in a temperature controlled water
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of the sample were placed on freshly cleaved mica, allowed to adsorb for about
5 min and then washed three times with 50 μl of water. The sample was
subsequently dried with a gentle stream of nitrogen. AFM images of the peptide
were obtained using a Multimode Nanoscope III (Digital Instruments, Santa
Barbara, CA) operated in tapping mode. Ultrasharp noncontact rectangular
silicon cantilevers with a spring constant of 40 N/m (MikroMasch, Wilsonville,
OR) were used with a scan rate of 1 Hz. Height and sizes of aggregates were
determined using the Nanoscope 5.12 program.
2.5. Total internal reflection fluorescence (TIRF) microscopy
Lipid bilayers were prepared on mica from a lipid mixture of DOPC:DPPC:
TR-DHPE (TR-DHPE content=0.5% mol/mol) as described above. A mixture
of fluorescein-labeled and unlabeled peptide was added to the bilayer (15% w/w
of Fl–Aβ) to give a final peptide concentration of ≈3 μM. All images were
collected using an Olympus IX2-RFAEVA 2 inverted microscope (Olympus
Corporation, Japan), equipped with a 488 nm Argon laser, a 543 nm He-Ne-G
laser and a 60 X TIRF oil immersion objective. The collected fluorescence
signal was detected using a CoolSnap ES CCD camera (Photometrics, Tucson,
AZ). Images were analysed using Image-Pro 5.1 software.
2.6. Fluorescence anisotropy measurements
Steady state fluorescence anisotropy measurements were performed using a
PTI fluorimeter equipped with xenon flash lamp and manual polarizers (Photon
Technologies International, South Brunswick, NJ). Excitation and emission
wavelengths were set at 360 and 427 nm, respectively. DOPC/DPPC vesicles,
prepared as described above, were diluted to a final lipid concentration of 250 μg/
ml and incubated for 1 hr with 1,6-diphenyl-1,3,5-hexatriene (DPH, Molecular
Probes) at 1:500 probe: lipid molar ratio. The fluorescence anisotropy of the
solution wasmeasured at room temperature before and after the addition of Aβ to
the vesicle solution (incubation for 1 hr; final peptide concentration 4 μM).
Fluorescence anisotropy was calculated as:
r ¼ IVV  gIVH
IVV þ 2gIVH
where IVV and IVH are the fluorescence intensity when the excitation and
emission polarizers are parallel and perpendicular, respectively. The g-factor
was calculated by exciting with horizontally polarized light and collecting




3.1. Phase separated DOPC/DPPC bilayers
AFM images of DOPC/DPPC (1:1 molar ratio) bilayers in
water show a phase separated membrane with higher gel phase
DPPC domains in a range of sizes and shapes surrounded by a
fluid DOPC phase (Fig. 1). This is consistent with an earlier
AFM study for this mixture [42] and with the phase transition
temperatures for DOPC and DPPC (−18 °C, and 40 °C, res-
pectively). As shown in Fig. 1A, bilayers imaged approximately
1 h after preparation typically showed domains with two distinct
heights; the higher domains extend ca. 1.2±0.1 nm (n=22)
above the fluid phase and range in size between 200 and 800 nm.
The lower domains are ca. 0.8±0.1 nm (n=16) higher than the
fluid phase and are located either on the edges of the higher
domains, or as isolated domains that range in size from 140 to
400 nm. The relative surface area covered by each type ofdomain varied from sample to sample and also changed with
time. For instance, the bilayer shown in Fig. 1A was imaged 1
day after preparation (Fig. 1B) and showed only larger domains
with a uniform height (1.3±0.2 nm (n=16)). Fig. 1C shows an
image of a freshly prepared bilayer that has predominantly the
higher domains (domain height=1.4±0.3 nm; n=25). Such
bilayers did not change significantly over a period of 48 h (data
not shown).
The presence of domains with two distinct heights is
attributed to a compositional asymmetry in the upper and
lower leaflets of the bilayers. The higher domains correspond to
areas in the membrane where DPPC molecules overlap in both
leaflets, while the shorter domains result from the asymmetric
transmembrane distribution of lipids (DOPC on DPPC, or vice
versa). The formation of domains with two different heights was
reported for phase separated lipid bilayers of DOPC/SM [43]
and DSPC/DLPC [44] and was explained by an asymmetric
distribution of lipids in the bilayer leaflets. By contrast, in a
previous study of DOPC/DPPC domains with a uniform height
of 1.21±0.03 nm were reported and were assigned to areas with
gel phase DPPC completely superimposed in the two leaflets
[42]. We attribute this domain symmetry to the higher
temperature used (60 °C) for both vesicle sonication and
bilayer formation [42]. This is consistent with the results of Lin
et al. which showed that the formation of symmetric domains in
DSPC/DLPC bilayers depended on the thermal history of the
sample [44] and with our observation that increases in
sonication temperature and time favor the formation of
symmetric domains in DOPC/DPPC bilayers.
3.2. AFM studies of the interaction of Aβ with DOPC/DPPC
bilayers
DOPC/DPPC bilayers were incubated with freshly prepared
solutions of 3 μMAβ(1–42) at room temperature. The peptide–
bilayer interaction was followed by imaging the bilayer in
aqueous solution after 60, 85, 90, 100 and 125 min of
incubation as shown for selected time points in Fig. 2. Small
aggregates of Aβ started to accumulate on the domains after
approximately 85–90 min (Fig. 2B), with an average height of
ca. 1.5±0.8 nm and a diameter ranging between 36 and 58 nm
(average diameter=45±7 nm). The height and diameter of the
aggregates increased with incubation time, and after approxi-
mately 125 min, the aggregates extend ca. 2.4±0.7 nm above
the fluid phase, and have an average diameter of 69±8 nm.
After 19 h, the extent of peptide accumulation increased, and
aggregates were observed uniformly distributed on the gel
phase of the bilayer (DPPC-rich domains) but were not detected
in the fluid phase. The aggregates extend ca. 4±1 nm (n=24)
above the fluid phase and are approximately 70–150 nm in
diameter (Fig. 2C). For comparison, a control bilayer of DOPC/
DPPC was prepared and imaged after 1 and 24 h (data not
shown). The domains in the control bilayer show no evidence
for the small aggregates observed for the peptide-incubated
bilayers. Note that the images at later time points which have
significant Aβ accumulation on the gel phase domains (Fig. 2C,
D) do not show sharp well-resolved peptide aggregates. This
Fig. 1. AFM images of 1:1 DOPC/DPPC bilayers showing a bilayer immediately (A) and 1 day after preparation (B) and a second bilayer immediately after preparation
(C). Scale bars are 1 μm and all images were obtained in water. Cross sections (height vs. surface distance) for the lines marked in images A and B are shown in panels
D and E, respectively.
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the membrane and thus are very easily moved by the tip, leading
to slightly fuzzy, streaky features.
For bilayers with both symmetric and asymmetric domains,
Aβ aggregates are observed exclusively on the higher domains
which contain DPPC in both leaflets. The accumulation on the
high domains, as opposed to the fluid phase or the lower
domains was maintained even after 48 h of incubation
(Fig. 2D). The absence of peptide aggregates on asymmetrical
domains suggests that these domains have DOPC in the upper
leaflet and DPPC in the leaflet proximal to the solid support, and
not vice versa.
Bilayers incubated with Aβ(1–42) for longer than 1 day
frequently developed a number of bilayer defects. However,
the extent of damage was not significantly larger than that
observed in control bilayers that were stored in water for a
similar length of time. Bilayers with significant membrane
damage also had large lipid aggregates which are not readily
distinguished from peptide, making it impractical to image
bilayers for longer periods of time. We obtained no evidenceFig. 2. AFM images of a 1:1 DOPC/DPPC bilayer before (A) and after incubation wi
after 48 h of incubation; in this case asymmetric domains are observed. Scale bars afor fibril formation for any of the incubation conditions (up to
2 days at room temperature).
Several experiments were carried out in order to help
distinguish between peptide aggregation in solution and on the
membrane. Note that the peptide concentration used for the
bilayer incubations is well below the typical threshold
concentration (10–20 μM) required for fibril or oligomer
formation in solution [45,46]. To confirm that the peptide
samples used aggregate to form the expected fibrils in solution
at high concentrations, we incubated Aβ samples at 1 mg/ml at
37 °C and observed significant yields of fibrils within 1 day
(Fig. 3A). By contrast, aliquots of freshly prepared 3 μM Aβ
(as used for bilayer experiments) imaged on mica showed only
small globular aggregates that were approximately 1.3 nm in
height with an apparent diameter of 20–30 nm. Heights of
∼1 nm are typically assigned to either monomers or small
oligomers of Aβ. Note that the apparent diameter is largely
determined by the size of the AFM tip and is less useful for
assessing the extent of oligomerization [45]. These experi-
ments, in combination with the fluorescence results describedth 3 μMAβ(1–42) for (B) 90 min and (C) 19 h. Image D shows a second bilayer
re 1 μm and all images were obtained in water.
Fig. 3. AFM images for peptide samples (dry, mica) after incubation of 1 mg/ml
solutions of Aβ (A) and Aβ/Fl–Aβ (9:1, B) at 37 °C for 24 h. Scale bars are
1 μm for all images.
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in solution.
3.3. TIRF microscopy studies of Aβ-bilayer interactions
Fluorescence microscopy was used to examine the interac-
tion of Aβ with supported bilayers in order to provide more
information about peptide–membrane interactions at early
times prior to the observation of peptide aggregates by AFM.
In these experiments 1:1 DOPC/DPPC vesicles were prepared
with 0.5% Texas Red-DHPE, which is known to partition
preferentially into fluid membrane phases [47]. Lipid bilayers
were prepared on mica as described above and imaged using a
total internal reflection fluorescence microscope. TIRF is an
interface sensitive method that probes fluorescence within
∼100 nm of the surface and therefore readily detects peptide
bound to the membrane with no background signal due to
residual labeled peptide in solution. Fig. 4A shows the
fluorescence image of a phase separated bilayer of DOPC/Fig. 4. TIRF images of a 1:1 DOPC/DPPC bilayer with 0.5% Texas Red-DHPE befo
30 min (B, 488 nm in green, C, 543 nm in red) and 19 h (D, 488 nm in green, E, 543
obtained in aqueous solution. (For interpretation of the references to colour in this fiDPPC/TR-DHPE after excitation with the 543 nm laser. The
dark areas correspond to DPPC gel phase domains from which
the fluorescent lipid is completely excluded. The domain size
ranges between 300 and 700 nm, consistent with that
determined from AFM images.
To follow the early stages of peptide–membrane interac-
tions, an aqueous solution of fluorescein-labeled and unlabeled
Aβ (3 μM, 85/15 Aβ/Fl–Aβ) was added to the bilayer in the
liquid cell. Excitation of the bilayer at 488 nm resulted in the
appearance of small fluorescent domains, indicating accumula-
tion of peptide on the bilayer. These bright domains were
detected as early as 8 min after peptide addition and were clearly
visible after 15 min. Shown in Fig. 4B, C are sequential 488 and
543 nm TIRF images of the bilayer 30 min after the addition of
the peptide. Comparison of Fl and Texas Red excitation showed
that the bright fluorescent domains due to the peptide
corresponded to the dark domains from which the Texas Red-
DHPE was excluded. The preferential accumulation of the
peptide on the gel phase was maintained even after 1 day of
incubation (consistent with AFM results for the unlabeled
peptide). Fig. 4D, E show 488 and 543 nm images of the bilayer
after 19 h of incubation with the peptide, indicating little change
in the intensity of the fluorescent domains over this time period.
For comparison an overlay of the two images demonstrating the
selective accumulation of peptide on the gel phase domains is
also shown (Fig. 4F). Note that there are a few larger domains in
these images as compared to images of the same bilayer at early
times, indicating some coalescence of smaller domains.
Although the accumulation of the peptide on the bilayer was
clearly detected using TIRF as early as 8 min after incubation,
AFM images of DOPC:DPPC:TR-DHPE bilayers incubated
with a mixture of Aβ and Fl–Aβ (85/15 w/w) reveal a low level
of peptide accumulation on the bilayer, even after 19 h ofre (A, 488 nm excitation) and after incubation with 3 μM Aβ/Fl–Aβ (85/5) for
nm in red; F, overlay of Fl and Texas Red). All images are 25×25 μm2 and were
gure legend, the reader is referred to the web version of this article.)
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the fluorescein label disrupts the aggregation of the peptide
and prevents the formation of large aggregates that can be
resolved with AFM. In fact, results of solution incubations of
a mixture of fluorescein-labeled (10% Fl–Aβ) and unlabeled
Aβ(1–42) show that the dye interferes with and delays the
aggregation of the peptide. For instance, after 24 h of
incubating unlabeled Aβ at 37 °C (conc.=1 mg/ml), AFM
images reveal the formation of long and medium length fibrils
(Fig. 3A). However, AFM images of the mixture of labeled
and unlabeled peptide, incubated under the same conditions,
indicate that fewer and shorter fibrils are formed (Fig. 3B). A
previous study of Aβ aggregation showed that 0.1 μM NBD-
labeled Aβ(1–40) did not interfere significantly with peptide
aggregation for 1–50 μM total peptide concentration [48].
Either the lower levels of labeled peptide, the fact that the dye
was attached via 2 additional “spacer” amino acids or
differences between Aβ(1–40) and Aβ(1–42) could account
for the much slower aggregation that we observe with Fl–Aβ.
3.4. Reconstitution of Aβ in DOPC/DPPC vesicles
The AFM and TIRF experiments both provide clear evidence
for selective interaction of Aβwith gel phase DPPC domains. In
order to test for any preference for gel vs. fluid phases for
samples in which the peptide was directly incorporated in the
bilayer, we reconstituted Aβ in DOPC/DPPC vesicles for
preparation of supported bilayers. AFM images of such bilayers
showed aggregates of Aβ(1–42) randomly distributed in both
the fluid and gel phases (Fig. 5). Aggregates in the fluid phase
are ca. 0.9±0.3 nm in height. Those present on the domains
extend approximately 1.4±0.3 nm above the fluid phase. The
aggregate diameter ranges between 30 and 100 nm, with an
average of 60±16 nm and neither the heights or diameters
increase over a period of several hours. The height of the
aggregates is in good agreement with earlier studies by Lal for
Aβ reconstituted in DOPC bilayers [24]. In this work high
resolution AFM images indicated formation of Aβ channels
comprised of tetrameric and hexameric peptide aggregates that
extended approximately 1 nm above the fluid DOPC bilayerFig. 5. AFM image of a 1:1 DOPC/DPPC bilayer with reconstituted Aβ (1:130
peptide/lipid ratio, scale bar of 1 μm, imaged in water). The bilayer was imaged
∼1 h after preparation and does not change with time over a period of several
hours.with diameters between 8 and 12 nm. At the level of resolution
shown in Fig. 5 it is not possible to determine whether the larger
aggregates that we detect correspond to clusters of oligomeric
channels or some other type of aggregate. However, it is useful
to note that the heights of the reconstituted peptide are
significantly less than those observed for Aβ aggregates
produced after several hours of incubation with preformed
DOPC/DPPC bilayers.
3.5. Fluorescence anisotropy studies
Fluorescence anisotropy measurements with DPH were used
to probe for possible peptide insertion in the membrane when
Aβ is incubated with preformed vesicles. DPH is sensitive to
changes in the lipid acyl chain ordering and has been used in a
number of earlier studies to aid in distinguishing between
inserted and surface adsorbed peptide [49–51]. The ratio of
DPH probe concentration in fluid and gel phases has been
shown to be independent of either probe concentration of
relative amounts of the two lipid phases [52]. Measured
anisotropies of 0.18±0.01 were obtained for DPH in DOPC/
DPPC vesicles alone, and incubating the vesicles with 3.6 μM
Aβ for 1 h did not result in any detectable change in anisotropy.
By contrast, reconstituting the peptide into vesicles at peptide:
lipid ratio of 1:25 resulted in a significant increase in anisotropy
to 0.27±0.01, consistent with earlier studies which showed that
peptide insertion leads to a decrease in membrane fluidity. Thus,
we conclude that addition of Aβ(1–42) to preformed DOPC/
DPPC vesicles does not lead to significant insertion of peptide
into the acyl chain region of the bilayer.
4. Discussion
Both AFM and TIRF results clearly demonstrate that Aβ
interacts preferentially with the ordered gel phase domains of
phase separated DPPC/DOPC bilayers. The two techniques
provide complementary data with fluorescence being particu-
larly useful to follow the association of Aβ with the bilayer at
early times before aggregates are detectable using AFM. The
accumulation of the unlabeled peptide on the membrane leads to
formation of small aggregates that can be detected after
approximately an hour and which continue to increase in size.
After approximately 1 day the aggregates have heights of 1–
3 nm, similar to the height of oligomers formed in solution
incubations at higher peptide concentrations [45,46]. There are
several pieces of evidence that suggest that the aggregation of
the peptide is facilitated by the membrane. Firstly, TIRF
imaging shows that the peptide accumulates on the gel phase
domains within a few minutes of adding Aβ to the bilayer, with
the gel phase domains showing a constant fluorescence intensity
after approximately 15 min. By contrast, peptide aggregates are
only detected after more than 1 h and continue to grow in size
over many hours. This result, plus the observation that
concentrations considerably higher than 3 μM are required to
promote Aβ oligomerization in solution (both from our studies
and the literature), are consistent with membrane adsorption of
peptide, followed by membrane facilitated aggregation. An
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monolayer promoted the formation of β-sheet structures that
were not present in aqueous solution [53]. Both the high local
concentration at the membrane surface and the formation of β-
sheet structures will facilitate aggregation on the gel phase
domains. We do not find any evidence for fibril formation or
bilayer damage, beyond that observed for control bilayers
stored for similar time in the absence of peptide.
The accumulation of Aβ on gel phase domains of DPPC/
DOPC bilayers does not appear to lead to insertion in the
membrane. This is supported by the following two experiments.
First, the fluorescence anisotropy results show clear differences
between direct incorporation of Aβ in lipid mixtures prior to
vesicle formation and the addition of Aβ to preformed vesicle
bilayer membranes. These differences are consistent with
peptide association with preformed bilayers leading to primarily
surface adsorption. Second, AFM images show very different
morphologies for Aβ reconstituted in bilayers as compared to
samples where peptide is incubated with preformed bilayers.
The lack of insertion of Aβ is in agreement with a previous
study that demonstrated that Aβ(1–42) adsorbs to the surface of
a DMPC monolayer but does not insert significantly or
otherwise perturb the membrane structure [53]. Furthermore,
studies of dye leakage from vesicles have indicated that 1 μM
Aβ(1–42) has minimal insertion in lipid vesicles [21,40]. It was
postulated that the repulsive forces between the hydrophilic
lipid head groups and the hydrophobic C-terminus of Aβ (1–
42) prevent the insertion of the peptide into the bilayer and favor
surface binding [40]. However, the lack of insertion is in
contrast to a recent study which reported that 7.5 μMAβ(1–42)
causes significant dye leakage from POPC and POPC/
sphingomyelin/cholesterol giant vesicles [22]. This apparent
discrepancy may be due to the different peptide concentrations
used.
Several previous studies have examined the interaction of
Aβ(1–42) and Aβ(1–40) with supported lipid bilayers using
AFM. Yip and McLaurin showed that incubation of Aβ(1–42)
with supported bilayers of total brain lipid extracts resulted in
the formation of small peptide aggregates that were randomly
distributed across the bilayer [40]. After incubation for 12 h,
these aggregates were 5–12 nm in height and 5–26 nm in width.
Although the uniform bilayers obtained from the total brain
extract mixture provide no information on the preference of the
peptide for ordered versus fluid phases, it was reported that a
higher cholesterol content in the bilayer led to increased
membrane rigidity (as assessed by DPH anisotropy) and a
concomitant increase in accumulation of Aβ(1–42). The
enhanced peptide accumulation on more rigid bilayers is
consistent with our observations of preferential accumulation
of peptide on ordered gel phase domains. The same study found
that Aβ addition induced a phase transition to generate an
interdigitated lipid phase.
By contrast to the above observations, an AFM study of the
interaction of Aβ(1–40) with supported bilayers of total brain
lipids indicated that small aggregates formed at early times
whereas fibrils started to appear after several hours [20]. Fibril
formation destabilized the bilayer and resulted in the appearanceof large lipid patches as well as defects in the membrane. In the
case of DMPC bilayers, small aggregates of Aβ, 1.2 to 1.5 nm
in height, were observed on the membrane. Although, the
aggregates increased in size and height with time and induced
damage to small areas of the bilayer, fibrils were not observed,
even after 24 h of incubation. Similarly, Green et al. examined
the interaction of Aβ(1–40) with POPC/POPG bilayers using
AFM [39]. Small peptide aggregates appeared within 1–2 h and
increased in size with time. After incubation overnight, AFM
images revealed the formation of small defects (damage) on the
bilayer. This study observed much more rapid deterioration of
POPC/POPG bilayers upon exposure to human amylin peptide.
Thus it is clear that the peptide structure, concentration and
incubation time all determine the aggregation behavior and
extent of membrane damage.
The accumulation and aggregation of Aβ on the symmetrical
gel phase DPPC domains, rather than the fluid phase or the
asymmetrical lower domains, was detected using both AFM and
TIRF and was maintained even after 48 h of incubation. Since
DOPC and DPPC have identical head groups, the observed
selectivity is probably the result of a preference for the more
ordered parts of the membrane, rather than any specific
interaction between the lipid head group and the peptide. The
orientation, packing and degree of hydration of the phospha-
tidylcholine head groups are all different for fluid and gel phase
membranes and presumably some combination of these factors
is responsible for the selective interaction of Aβ with DPPC
domains. Interestingly, a similar preferential interaction with gel
phase DPPC domains has been observed recently by AFM for
both ApoE and cell-penetrating peptides [54,55]. Although both
these examples led to significant peptide induced changes in
membrane morphology, the overall preference for interaction
with DPPC rather than surrounding fluid membrane parallels
the results reported here for Aβ.
The observation that Aβ does not accumulate on the
asymmetrical lower domains suggests that they contain DOPC
in the upper leaflet. These asymmetric domains are not stable
and slowly convert to symmetrical domains with DPPC in both
leaflets. The instability of bilayers with mixtures of symmetric
and asymmetric domains is analogous to previous observations
for DSPC/DLPC mixtures [44]. However, there is an important
difference in that the DOPC/DPPC bilayers convert to
symmetric domains whereas the DLPC/DSPC bilayers undergo
a rapid transleaflet lipid redistribution to give a bilayer with
complete compositional asymmetry with large DSPC domains
only in the top leaflet of the bilayer. Clearly additional studies
are required to understand the factors that control the
asymmetry and lipid mobility in bilayers with mixtures of gel
and fluid phases.
Many previous studies that examined the interaction of Aβ
with membranes have focused on the role of cholesterol and
charged lipids or gangliosides. In most cases it was suggested
that electrostatic interactions increase the local concentrations
of peptide on the membrane surface, thus enhancing the
aggregation efficiency. However, the present studies show that
there is a strong preference for association of peptide with the
ordered gel phase domains in a simple mixture of high and low
153A. Choucair et al. / Biochimica et Biophysica Acta 1768 (2007) 146–154melting phosphatidylcholines. Our results indicate that charged
lipids or cholesterol are not required to promote accumulation of
Aβ on specific regions of the membrane. In this context, we
note that our studies used 3 μM peptide which is significantly
lower than the concentrations used in earlier AFM studies of Aβ
[39,40]. The preferential accumulation of peptide on ordered
domains in a binary lipid mixture is also of interest in the
context of recent studies that implicate lipid rafts in Aβ
accumulation and toxicity. For example, a number of studies in
brain and cell culture show that a significant fraction of cellular
Aβ is isolated from detergent resistant membrane fractions [32–
34]. Other work has shown that the generation of Aβ by
enzymatic cleavage of APP is regulated by partitioning into
lipid rafts [37]. Of particular interest is a recent investigation
reporting that the onset of memory deficit in a transgenic mouse
model for Alzheimer's disease coincides with the accumulation
of soluble dimeric Aβ in rafts and not with the formation of
insoluble fibrils [38]. This has led to the hypothesis that Aβ
aggregation may be initiated in lipid rafts with the formation of
toxic oligomers at sites where they are well positioned to
interfere with signal transduction. Consistent with this, an
earlier study showed that small oligomers of Aβ(1–42) bind to
protein-sensitive domains on B103 and hippocampal cell
surfaces, and act as a potent toxin to cultured neurons [6].
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